S

Senolytic Therapeutics

2 employees

Senolytic Therapeutics (STX) is a pharmaceutical company that develops a novel class of medicines by targeting damaged cells.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Medical Device
Alternative Medicine
Medical
Pharmaceutical
Biopharma
Robotics

Date founded

2017

Funding rounds raised

Total raised

$84K

from 1 investors over 1 rounds

S

Senolytic Therapeutics raised $84K on August 1, 2018

Investors: Executive Agency for Small and Medium-sized Enterprises (EASME)

FAQ